Analysts Offer Insights on Healthcare Companies: Sienna Biopharmaceuticals Inc (SNNA), Global Blood Therapeutics (GBT) and Tesaro (TSRO)


Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sienna Biopharmaceuticals Inc (SNNA), Global Blood Therapeutics (GBT) and Tesaro (TSRO).

Sienna Biopharmaceuticals Inc (SNNA)

In a report released yesterday, Ken Cacciatore from Cowen & Co. maintained a Buy rating on Sienna Biopharmaceuticals Inc, with a price target of $45. The company’s shares closed yesterday at $6.31, close to its 52-week low of $5.53.

According to TipRanks.com, Cacciatore is a 3-star analyst with an average return of 1.6% and a 45.2% success rate. Cacciatore covers the Healthcare sector, focusing on stocks such as Liquidia Technologies Inc, Supernus Pharmaceuticals, and Alder Biopharmaceuticals.

Sienna Biopharmaceuticals Inc has an analyst consensus of Moderate Buy, with a price target consensus of $45.

See today’s analyst top recommended stocks >>

Global Blood Therapeutics (GBT)

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Global Blood Therapeutics yesterday and set a price target of $83. The company’s shares closed yesterday at $46.62.

According to TipRanks.com, Baral is a top 100 analyst with an average return of 26.4% and a 48.8% success rate. Baral covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals Inc, Allena Pharmaceuticals Inc, and Ionis Pharmaceuticals Inc.

Global Blood Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $90.88, which is a 94.9% upside from current levels. In a report issued on November 28, H.C. Wainwright also maintained a Buy rating on the stock with a $125 price target.

.

Tesaro (TSRO)

In a report released yesterday, Boris Peaker from Cowen & Co. maintained a Hold rating on Tesaro, with a price target of $38. The company’s shares closed yesterday at $73.50.

According to TipRanks.com, Peaker is a 4-star analyst with an average return of 6.8% and a 43.1% success rate. Peaker covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals Inc, Stemline Therapeutics Inc, and Mersana Therapeutics Inc.

Tesaro has an analyst consensus of Moderate Buy, with a price target consensus of $60.79, which is a -17.3% downside from current levels. In a report released yesterday, Leerink Partners also downgraded the stock to Hold with a $75 price target.

.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts